About BioSymetrics
BioSymetrics is a company based in New York (United States) founded in 2015. BioSymetrics has raised $4.88 million across 1 funding round. BioSymetrics offers products and services including AI Discovery Platform. BioSymetrics operates in a competitive market with competitors including Causaly, Atomwise, ScienceIO, MicroHealth and Collaborative Drug Discovery, among others.
- Headquarter New York, United States
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Lunfarda Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.88 M (USD)
in 1 rounds
-
Latest Funding Round
$4.88 M (USD), Series A
Aug 04, 2021
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioSymetrics
BioSymetrics offers a comprehensive portfolio of products and services, including AI Discovery Platform.
Uses machine learning to predict and validate targets for precision medicines
People of BioSymetrics
Unlock access to complete
Unlock access to complete
Funding Insights of BioSymetrics
BioSymetrics has successfully raised a total of $4.88M through 1 strategic funding round. The most recent funding activity was a Series A round of $4.88 million completed in August 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $4.9M
-
First Round
First Round
(04 Aug 2021)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2021 | Amount | Series A - BioSymetrics | Valuation |
investors |
|
Investments & Acquisitions by BioSymetrics
Financial Statements - BioSymetrics
Biosymetrics Comparisons
Competitors of BioSymetrics
BioSymetrics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Causaly, Atomwise, ScienceIO, MicroHealth and Collaborative Drug Discovery, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-based data-mining tools for scientific evidence discovery are provided.
|
|
| domain | founded_year | HQ Location |
AI-driven platform for structure-based drug discovery is provided.
|
|
| domain | founded_year | HQ Location |
Provider of AI solutions transforming medical text into enriched healthcare data
|
|
| domain | founded_year | HQ Location |
Population health management and care coordination solutions are provided.
|
|
| domain | founded_year | HQ Location |
Biological and chemical data are managed securely in a database.
|
|
| domain | founded_year | HQ Location |
Drug development solutions are delivered via cognitive computing platform.
|
Latest news on Biosymetrics
Frequently Asked Questions about BioSymetrics
BioSymetrics was founded in 2015 and raised its 1st funding round 6 years after it was founded.
BioSymetrics is headquartered in New York, United States. It is registered at New York, New York, United States.
BioSymetrics is a funded company, having raised a total of $4.88M across 1 funding round to date. The company's 1st funding round was a Series A of $4.88M, raised on Aug 04, 2021.
BioSymetrics was founded in 2015 and is based in New York, United States. Operations focus on the biomedical sector, where a platform for cognitive computing is provided. Services include data pre-processing, analytics, and zero-latency machine learning applied to bioinformatics, RD clinical informatics, target discovery, and computational biology. Predictive analytics are also delivered for various RD and healthcare datasets.
BioSymetrics offers AI Discovery Platform.